Philips will highlight its newly released MicroDose Mammography System at RSNA 2011. The Philips unit will go head to head with other new entries in the mammography space including Hologic’s 3-D breast tomosynthesis product, Selenia® Dimensions, whole breast ultrasound from U-Systems, Dilon’s 6800 MBI scanner, and GE’s Discovery MB750b, a molecular breast imaging system.
Philips will highlight its newly released MicroDose Mammography System at RSNA 2011.
The Philips unit will go head to head at RSNA with other new entries in the mammography space including Hologic’s 3-D breast tomosynthesis product, Selenia® Dimensions (previewed at RSNA in 2010 and FDA approved in February 2011), whole breast ultrasound from U-Systems, Dilon’s 6800 MBI scanner, and GE’s Discovery MB750b, a molecular breast imaging system.
Philips’ system is the first in the US to use photon-counting technology, designed to improve clarity while reducing dose. Photon counting reduces the number of intermediate conversion steps needed to create a digital signal. Each conversion can reduce image quality. The MicroDose system delivers no ghost images and a 50 µm pixel size at 100 percent pixel accuracy, according to Kim Holttum, senior director of global marketing, Women’s Health Care, Philips Healthcare. The field of view is 24 by 26 cm.
Plus, the dose is about half that of full-field digital mammography (FFDM) systems, Holttum says. Automatic exposure control (AEC) can adjust dose based on breast density.
The units also are fast. With no wait time between acquisitions, exams take only 4 minutes, making it possible to do 12 to 18 exams an hour, Holttum estimates. That’s good for patients, technologists, and the bottom line.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Reducing the Interval Breast Cancer Rate of Screening DBT: Can AI Have an Impact?
July 31st 2025In a retrospective review of screening digital breast tomosynthesis (DBT) exams for over 200 women with interval breast cancers, researchers found that AI provided accurate localization of cancers in 32.6 percent of the cases.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 2
July 31st 2025In the second part of a multi-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, discuss key sequences for abbreviated breast MRI and how it stacks up to other breast cancer screening modalities.
Mammography Study: AI Facilitates Greater Accuracy and Longer Fixation Time on Suspicious Areas
July 31st 2025While noting no differences in sensitivity, specificity or reading time with adjunctive AI for mammography screening, the authors of a new study noted a 4 percent higher AUC and increased fixation time on lesion regions.